Pandemic influenza preparedness and community resiliency.

Pandemic influenza preparedness and community resiliency. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pandemic influenza preparedness and community resiliency. Abstract Text:

John P Middaugh,John P Middaugh,

Pandemic influenza preparedness and community resiliency. Publishing Authors By Initials

JP Middaugh,JP Middaugh,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pandemic influenza preparedness and community resiliency. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: JAMA : the journal of the American Medical Associa

VOLUME: 299

Page Numbers: 566-8

Journal Abbreviation: JAMA

ISSN: 1538-3598

DAY: 6

MONTH: Feb

YEAR: 2008

Pandemic influenza preparedness and community resiliency. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7501160

Pandemic influenza preparedness and community resiliency. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pandemic influenza preparedness and community resiliency. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pandemic influenza preparedness and community resiliency.

AFFILIATION: State Epidemiologist, Florida Department of Health, Tallahassee, FL 32399-1708, USA. john_middaugh@doh.state.fl.us

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: JAMA

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pandemic influenza preparedness and community resiliency Related Publications

• A Review of: Vaccine Adjuvants and Delivery Systems.
• A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams.
• A network-based analysis of polyanion-binding proteins utilizing human protein arrays.
• A network-based analysis of polyanion-binding proteins utilizing yeast protein arrays.
• A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine.
• A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine.
• Conformational flexibility, hydration and state parameter fluctuations of fibroblast growth factor-10: effects of ligand binding.
• Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants.
• Immunoglobulin dynamics, conformational fluctuations, and nonlinear elasticity and their effects on stability.
• Intravenous cocaine self-administration: individual differences in male and female C57BL/6J mice.
• Linked outbreaks of hepatitis A in homosexual men and in food service patrons and employees.
• Pandemic influenza preparedness and community resiliency.
• Periadolescent nicotine exposure reduces cocaine reward in adult mice.
• Physical characterization of clostridium difficile toxins and toxoids: effect of the formaldehyde crosslinking on thermal stability.
• Physical stabilization of norwalk virus-like particles.
• Positions of authority may equal lawsuits.
• Preformulation studies of Clostridium difficile toxoids A and B.
• Side effects of diphtheria-tetanus toxoid in adults.
• Spectroscopic methods for the physical characterization and formulation of nonviral gene delivery systems.
• Stabilization of measles virus for vaccine formulation.
• Stabilization of proteins by recombinant human gelatins.
• The analysis of protein pharmaceuticals: near future advances.
• The complex inter-relationships between protein flexibility and stability.
• The interaction of heparin/polyanions with bovine, porcine, and human growth hormone.
• The structure, stability, and complex behavior of recombinant human gelatins.
• pH sensitivity of type III secretion system tip proteins.